How much funding has Owkin raised?

Owkin has raised $445.2M in total funding, most recently a Corporate Round.

Who are Owkin's investors?

Owkin's investors include Bpifrance, Sanofi Ventures, Mubadala Capital, F-Prime Capital, Eight Roads Ventures, Otium Capital.

Where is Owkin headquartered?

Owkin is headquartered in San Francisco, California, United States.

What industry is Owkin in?

Owkin operates in Artificial Intelligence, Biotech, Healthcare.

Owkin

Building Biological Artificial Superintelligence

San Francisco, United States · Founded 2016 · $445.2M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 201–500
Founded: 2016
Business Model: B2B

Website: owkin.com
Total Funding: $445.2M
Last Round: $80.0M Corporate RoundJan 2023
Rounds: 10

About

Owkin is an AI biotech company pioneering biological artificial superintelligence to transform drug discovery and clinical trials. Using federated learning and agentic AI, Owkin processes multimodal patient data from hospitals and academic institutions to discover new biology and accelerate drug development. Its flagship product K Pro is an AI agent connecting research and clinical care.

Summary

Owkin is an Artificial Intelligence company based in San Francisco, United States, founded in 2016. It has raised $445.2M in total across 10 rounds, most recently a $80.0M Corporate Round round in Jan 2023. Investors include Bpifrance, Sanofi Ventures and Mubadala Capital.

LinkedIn X (Twitter)GitHub